Disease associations · Patient foundations

Your patients said yes to research. Not to everything

A foundation's real assets are its patients' trust and the centres that care for them. Once a file leaves, consent language is usually a hope. On CuRE it is a rule the data platform checks before anything moves, and your network becomes something you can ask a question of without becoming a data warehouse

Trust you can enforce

Four things foundations don't think to ask for

Each one usually lives in a contract, an inbox or a spreadsheet. Here each one is something the platform does

01

The fine print holds

Write down the purposes an agreement allows, from clinical research to safety surveillance. When a partner declares any other purpose for a release, market access for instance, the release is refused before a single row moves, even though the agreement is active

Purpose-checked data release

02

Ask forty centres without collecting a record

Enter a sponsor's criteria once. The question runs inside each centre's own records, under that centre's own rules, and only a privacy-protected total comes back. No patient-level row leaves any centre, and nobody spends six weeks chasing coordinators

Federated feasibility counts

03

Out of one deal, still in the registry

A patient who objects to one partnership can leave just that agreement. The withdrawal reaches the data platform, the patient portal, the site's EDC and the randomization system in one step, and her natural-history data stays in the registry she still supports

Per-agreement withdrawal

04

The committee clicks Grant, and that is the access control

An outside investigator applies on the dataset's own page. The committee sees aggregate counts with small cells hidden and an advisory summary against your policy. Access is issued against the signed agreement and the IRB reference, so a revoked agreement actually stops the data

Data access committee workflow

One network

From the agreement to the results letter

The same rules travel with the data at every step, so a foundation can say yes to more partners without promising its patients less

01

Agree

The purposes each partner may use your data for are written once and checked on every release, by every partner, at every centre

02

Ask

A sponsor's "how many patients can you reach?" becomes one question to the whole network instead of forty emails

03

Find

Designed to show which community centres actually see the patients your registry is missing, read from their own records before a trial picks its sites

04

Study

Built toward the day a trial runs inside the population you already follow, with a separate consent for randomization checked on every draw

05

Give back

Trial results return to every participant in plain words, drafted from the locked results and checked by study operations before they appear on the portal

Why foundations sit at the centre

Every centre that joins makes your next answer better

A foundation is the one organization every centre in its disease already trusts. That makes it the natural place for a research network to start, and the place where the cost of a broken promise is highest

On CuRE the network compounds. A centre that connects for any reason, a sponsor's trial or its own registry work, makes your next count more complete. A pharma partner working with three foundations meets the same enforced terms at each. And the centres get something back: their own patients' data, cleaned and harmonized, instead of an annual PDF

That is the exchange: centres supply the data, partners need it, and the foundation keeps the terms

Outcomes, not features

What changes for a foundation

Most research software automates the handoffs between systems. CuRE is built to remove them, so the difference shows up as questions you can finally ask and work nobody has to redo

New questions

Ask the questions you stopped asking

Is this subject enrolled in someone else's trial? How many eligible patients sit across forty centres? Did the cold chain matter to the outcome? Questions that used to start a data project are designed to be a query on one shared record

Fewer handoffs

Map once. Stop re-typing

Data maps to OMOP once and every app reads the same record. Next month's CRO file is recognized and replays in one click, and the same value is never keyed into three systems to be reconciled later

Time to evidence

Start from data that is already there

A new study, a sponsor's feasibility question or a fresh safety signal starts from the record that already exists, not from a new extract and a data-engineering project

Evidence as a byproduct

The audit trail writes itself

Signatures are bound to the exact content they approved, every AI suggestion is sealed with the model that made it, and a CAPA can close on the metric it was meant to fix. Inspection evidence comes out of the work itself

One platform

One record instead of a vendor stack

Randomization, safety, quality, TMF and analytics share one data model, so adding a capability means switching it on rather than buying another integration project and validating it again

Bring us the question your network can't answer yet

A sponsor's feasibility request, a consent promise you can't enforce, a registry that should be running a trial: tell us which one keeps coming back